Abstract

8 Oral - Safety and preliminary clinical activity of NVL-520, a highly selective ROS1 inhibitor, in patients with advanced ROS1 fusion-positive solid tumors

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
1575P - Preliminary results from phase Ib study of spartalizumab plus chemotherapy for advanced non-small cell lung cancer (NSCLC)
J.F Vansteenkiste ... S Eddy
Annals of Oncology | VOL. 30
J.F Vansteenkiste, et. al.J.F Vansteenkiste ... S Eddy
01 Oct 2019
First-in-human phase I results of APG-2449, a novel FAK and third-generation ALK/ ROS1 tyrosine kinase inhibitor (TKI), in patients (pts) with second-generation TKI-resistant ALK/ROS1+ non–small cell lung cancer (NSCLC) or mesothelioma.
Ruiguang Zhang ... Li Zhang
Journal of Clinical Oncology | VOL. 40
Ruiguang Zhang, et. al.Ruiguang Zhang ... Li Zhang
01 Jun 2022
1886P - Prospective pathological experience with research biopsies in the context of clinical trials at Vall d’Hebron Institute of Oncology
C Sevillano ...
Annals of Oncology | VOL. 30
C Sevillano, et. al.C Sevillano ...
01 Oct 2019
Abstract B154: Safety and preliminary activity of the selective ALK inhibitor NVL-655 in patients with ALK fusion-positive solid tumors
Jessica J Lin ... Junwu Shen
Molecular Cancer Therapeutics | VOL. 22
Jessica J Lin, et. al.Jessica J Lin ... Junwu Shen
01 Dec 2023
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
Pasquale Rescigno ... Johann De Bono
European Journal of Cancer | VOL. 205
Pasquale Rescigno, et. al.Pasquale Rescigno ... Johann De Bono
08 May 2024
Trends in incidence, treatment, and relative survival of colorectal cancer in the Netherlands between 2000 and 2021
Hidde Swartjes ... Johannes H.W De Wilt
European Journal of Cancer | VOL. 205
Hidde Swartjes, et. al.Hidde Swartjes ... Johannes H.W De Wilt
07 May 2024
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases
Ines Pires Da Silva ... Georgina V Long
European Journal of Cancer | VOL. 205
Ines Pires Da Silva, et. al.Ines Pires Da Silva ... Georgina V Long
07 May 2024
ChatGPT's Gastrointestinal Tumor Board Tango: A limping dance partner?
Ughur Aghamaliyev ... Bernhard W Renz
European Journal of Cancer | VOL. 205
Ughur Aghamaliyev, et. al.Ughur Aghamaliyev ... Bernhard W Renz
07 May 2024
View more papers